Related Experiment Video
Updated: Apr 7, 2026

Bioluminescence Imaging of Neuroinflammation in Transgenic Mice After Peripheral Inoculation of Alpha-Synuclein Fibrils
Published on: April 13, 2017
Transgenic over-expression of mammalian heparanase delays prion disease onset and progression
O Kovalchuk Ben-Zaken1, I Nissan2, S Tzaban2
1Department of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, 91120, Israel; Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, 31096, Haifa, Israel.
Abstract:
Cellular heparan sulfate (HS) has a dual role in scrapie pathogenesis; it is required for PrP(Sc) (scrapie prion protein) formation and facilitates infection of cells, mediating cellular uptake of prions. We examined the involvement of heparanase, a mammalian endoglycosidase degrading HS, in scrapie infection. In cultured cells, heparanase treatment or over-expression resulted in a profound decrease in PrP(Sc). Moreover, disease onset and progression were dramatically delayed in scrapie infected transgenic mice over-expressing heparanase. Together, our results provide direct in vivo evidence for the involvement of intact HS in the pathogenesis of prion disease and the protective role of heparanase both in terms of susceptibility to infection and disease progression.

